Results 131 to 140 of about 491,626 (323)
Chimeric antigen receptor T cells (CAR T) targeting CD7 for T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) showed promising efficacy and safety in some clinical trials.
Ying Jiang +7 more
doaj +1 more source
scRNA‐Seq reveals anti‐lymphoma immune responses in mogamulizumab‐associated skin eruptions
CCR4 was expressed in malignant clones and regulatory T cells in untreated CTCL, that were decreased in MAR. Malignant clones in MAR showed a silenced phenotype with decreases in central memory markers SELL and CCR7, and GTP‐binding member GIMAP7 and upregulation of MMP2 inhibitor TIMP2 and tumour suppressor gene RUNX3.
Shannon Meledathu +13 more
wiley +1 more source
Lymphoblastic leukaemia and non-Hodgkin's lymphoma [PDF]
J S Lilleyman, CR Pinkerton
openalex +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Farzan Solimani +9 more
wiley +1 more source
ABSTRACT Aim To explore challenges parents of children with cancer encounter while providing complex medical care at home. Methods Design: Cross‐sectional convergent mixed‐methods study. Instruments: Questionnaire and open interviews that mirrored and complemented each other.
Rachel Klausner Shyman +5 more
wiley +1 more source
A Role for the Fas/FasL System in Modulating Genetic Susceptibility to T-Cell Lymphoblastic Lymphomas [PDF]
María Villa‐Morales +4 more
openalex +1 more source
Characteristics of Acyclovir‐Resistant Herpes Simplex Virus Infection in Hematological Patients
ABSTRACT Objective Acyclovir‐resistant herpes simplex virus infections pose a significant challenge in immunosuppressed patients. This study aimed to characterize the clinical features, treatment outcomes, and mortality associated with acyclovir‐resistant herpes simplex virus infection. Materials and Methods A retrospective analysis was conducted on 18
Reema Shehadeh +7 more
wiley +1 more source
This single‐center retrospective cohort study on 300 allogeneic hematopoietic stem cell transplant recipients from January 2017 to May 2020, in which posaconazole modified release was the most common primary antifungal prophylaxis, demonstrated a breakthrough invasive fungal disease (bIFD) rate of 9%, with associated significant all‐cause mortality at ...
Shio Yen Tio +7 more
wiley +1 more source
Precursor NK cell lymphoblastic leukemia/lymphoma - report of a case with literature review
Precursor Natural Killer cell lymphoblastic leukemia/lymphoma is a rare entity defined clearly by WHO (2008 WHO classification). However, the pathobiology of this subset of neoplasms is not clearly defined.
Sonal Jain +3 more
doaj
This retrospective study analyzed the incidence of CMV infections among 179 patients who received CAR T‐cell or BsAb therapy for hematologic malignancies. CMV infections occurred in 43% in CAR T‐cell and 62% in BsAb recipients, with 1–4% progressing to CMV diseases.
Juhui Han +5 more
wiley +1 more source

